CharneyRLeddomadoERoseDNFusterV. Anticoagulation clinics and the monitoring of anticoagulant therapy. Int J Cardiol1988; 18: 197–206.
2.
ErrichettiAMHoldenAAnsellJ. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med1984; 144: 1966–8.
3.
AlbertsMJMasseyEWDawsonD. A multicenter Study of anticoagulation parameters when using heparin and warfarin. Arch Neurol1987; 44: 1229–31.
4.
DobleNBaronJH. Anticoagulation control with warfarin by junior hospital doctors. J R Soc Med1987; 80: 627.
5.
HirschJLevineMN. The optimal intensity of oral and anticoagulant therapy. JAMA1987; 258: 2723–6.
6.
LoeligerEA. Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation. Acta Haematol1985; 74: 125–31.
7.
LoeligerEA. International Committee for Standardization in Haematology/International Committee on Thrombosis and Haemostasis, recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost1985; 53: 155–6.
8.
LoeligerEA. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemost1985: 148–53.
9.
ShintonNK. Therapeutic control of anticoagulant treatment. Br Med J1982; 284: 1871.
10.
ZatuchniJ. Anticoagulation control with warfarin by junior hospital doctors (letter). J R Soc Med1988; 81: 246.
11.
Van Den BesselaarAMHPVan MansfeldHVan Der MeerFJM. Thrombosis and hemostasis no. TH 87–3 (TH-51). International normalized ratio (INR) for monitoring oral anticoagulant treatment. Thromb Haemost1987; 9: 1–8.
PalmerRNKesslerCMGralnickHR. Warfarin anticoagulation: Difficulties in interpretation of the prothrombin time. Thromb Res1982; 25: 125–30.
14.
Richton-HewettSFosterEApsteinCS. Medical and economic consequences of a blinded oral anticoagulant brand change at a municipal hospital. Arch Intern Med1988; 148: 806–8.
15.
HowardMRMilliganDW. Frequency of attendance at anticoagulant clinics: A prospective study. Br Med J1988; 296: 898–9.
